- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
As Cold War rhetoric escalates in Russia, U.S. military contractors prepare to get busy.
The Fed's cheap-money fix will only prolong the crisis, but you can find safe haven in some banks.
These veteran market watchers tell you how to brace yourself for the coming knocks.
While retail investors flee the stock market, this private-equity master is swooping in for bargains.
This could be an excellent way to play alternative energy.
The global building boom is stoking demand for basic materials.
The card issuer is hugely undervalued, and it has an edge over its competitors.
The tech rally has legs, and Intel is set to grab the baton.
Smokestack industries are staging a revival, and you can still get in at a good price.
They're creating therapies that use stem cells' healing capacity.